Alcami Executive and Leadership Team

Roz Stone, the Earthware Enterprise Chief Executive Officer at Alcami, directs the overarching strategic vision for the organization. By aligning corporate objectives with the evolving needs of the pharmaceutical and biotech sectors, Stone architects long-term growth initiatives that leverage the company's extensive manufacturing footprint. This leadership role involves constant collaboration with the Board to ensure operational excellence across all service lines, including sterile manufacturing and analytical development. Roz Stone maintains a sharp focus on market expansion, driving North American initiatives to solidify the company's position as a premier contract development and manufacturing organization. Through the optimization of internal resources and the pursuit of technological advancements, Stone ensures that the enterprise remains agile in a competitive landscape. By fostering a culture of innovation and precision, the Chief Executive Officer secures the company's reputation for delivering high-quality, customizable solutions that support clients from clinical stages through commercialization.

Tori Arens, the President, Drug Product at Alcami, oversees the clinical to commercial sterile and oral solid manufacturing divisions. By managing the complex production workflows across the company's 675,000 square feet of facility space, the President, Drug Product ensures that all manufacturing processes adhere to strict cGMP guidelines. Tori Arens directs the integration of advanced packaging and microbiology services into the broader drug product lifecycle, providing clients with seamless, end-to-end support. This leadership role involves coordinating with the laboratory operations team to ensure that analytical development findings translate effectively into large-scale production. Arens drives operational efficiency by implementing lean manufacturing principles and optimizing supply chain logistics for pharmaceutical partners. By focusing on technical precision and regulatory compliance, the President, Drug Product maintains the high standards required for sterile manufacturing, ultimately supporting the successful commercialization of life-saving medications for clients of all sizes throughout the United States.

Katie Schlipp, the President, Laboratory Operations at Alcami, manages the analytical development and pharmaceutical support services that form the foundation of the company's technical offerings. Overseeing a network of specialized laboratories, the President, Laboratory Operations ensures that all testing, microbiology, and environmental monitoring activities meet the highest regulatory benchmarks. Katie Schlipp architects the strategic direction for laboratory capacity, ensuring that the company can handle the diverse requirements of pharmaceutical and biotech clients. This leadership role involves close collaboration with the drug product manufacturing team to provide the data-driven insights necessary for successful product development. By investing in advanced instrumentation and scientific talent, Schlipp drives the continuous improvement of analytical methodologies. Through the oversight of these critical support services, the President, Laboratory Operations ensures that every project benefits from rigorous scientific validation, thereby reducing risk and accelerating the development lifecycle for partners across the North American market.

Rose-Marie Nelson, the Chief Human Resources Officer at Alcami, manages the talent acquisition and organizational development strategies necessary to support a workforce of over 40 years of industry experience. Overseeing the recruitment of specialized scientific and manufacturing personnel, the Chief Human Resources Officer ensures that the company maintains the technical expertise required for complex cGMP biostorage and pharmaceutical support services. Rose-Marie Nelson designs comprehensive training programs that align with the rigorous environmental monitoring and quality standards essential to the pharmaceutical industry. By cultivating a high-performance culture, Nelson drives employee engagement and retention across all regional facilities. This leadership role involves partnering with other C-suite executives to integrate human capital strategies with broader business goals, ensuring that the organization possesses the human infrastructure to scale operations effectively. Ultimately, the Chief Human Resources Officer strengthens the company's internal capabilities, directly impacting the ability to deliver consistent, innovative solutions to global biotech partners.